Given that a single AAV9 injection elicited very long cardiac transduction (at least up to 18 months, Figure 1), cardiac gene delivery of BNP could be useful in subjects with uncontrolled hypertension and concomitant HHD to improve cardiac function and structure. The gene discussed is NPPB; the disease is Hypertension.